ArticleStroke and vascular neurology2024

Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial.

Yu Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.